Evaluation of Tolerance, Efficacy and Safety of an Hydrolyzed Formula in Infants With IgE/Non-IgE Mediated CMA.

NCT06481280 · clinicaltrials.gov ↗
NA
Phase
ACTIVE_NOT_RECRUITING
Status
70
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

United Pharmaceuticals

Collaborators